Research map: Effectiveness and waning of the fourth dose mRNA COVID-19 vaccines for the prevention of SARS-CoV2 infection related hospitalisations and deaths

Back to the article

Papers in this map

  1. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies · Erik B von Elm · 2007 · 20683 citations · Cited by this paper
  2. A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment · 2026 · Related
  3. Data Resource Profile: Clinical Practice Research Datalink (CPRD) · Emily L. Herrett · 2015 · 2781 citations · Cited by this paper
  4. Global surveillance reveals progressive erosion of benzylpenicillin susceptibility in Streptococcus suis · 2026 · Related
  5. Negative Controls · Marc Lipsitch · 2010 · 1584 citations · Cited by this paper
  6. Home-based rapid testing and early antiviral treatment as a potential strategy to blunt pediatric influenza peak · 2026 · Related
  7. Interpreting observational studies: why empirical calibration is needed to correct p‐values · Martijn J. Schuemie · 2013 · 249 citations · Cited by this paper
  8. Remdesivir triphosphate as a potential repurposed drug against the emerging Bundibugyo Ebolavirus 2026 · 2026 · Related
  9. Data Resource Profile: The Information System for Research in Primary Care (SIDIAP) · Martina Recalde · 2022 · 172 citations · Cited by this paper
  10. Metagenomic sequencing as a diagnostic tool for urine culture negative febrile urinary tract infection · 2026 · Related
  11. Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study · Sara Yee Tartof · 2022 · 154 citations · Cited by this paper
  12. Global disability-adjusted life years burden of lower respiratory infections caused by Streptococcus pneumoniae, Staphylococcus aureus, and Klebsiella pneumoniae, 1990–2021: A systematic analysis of the global burden of disease study 2021 · 2026 · Related
  13. OHDSI Standardized Vocabularies—a large-scale centralized reference ontology for international data harmonization · Christian Reich · 2023 · 142 citations · Cited by this paper
  14. Long-term immunogenicity and safety of RZV primary vaccination and revaccination in kidney transplant recipients · 2026 · Related
  15. Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022 · Ruth Link‐Gelles · 2022 · 138 citations · Cited by this paper
  16. Serological outcomes of SARS-CoV-2 infection by vaccination status and variant in England · 2026 · Related
  17. Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023 · Jeffrey Victor Lazarus · 2024 · 122 citations · Cited by this paper
  18. Determinants of fatalities and secondary transmission in laboratory pathogen incidents, 1900–2025 · 2026 · Related
  19. Data Resource Profile: The Integrated Primary Care Information (IPCI) database, The Netherlands · Maria A. J. de Ridder · 2022 · 83 citations · Cited by this paper
  20. Within-host evolution of tandemly duplicated blaKPC-14 conferring cross-resistance to ceftazidime-avibactam, cefiderocol and aztreonam-avibactam in hypervirulent ST11 Klebsiella pneumoniae · 2026 · Related
  21. Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study · Celine Y. Tan · 2023 · 55 citations · Cited by this paper
  22. Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization · Daniel R. Feikin · 2023 · 40 citations · Cited by this paper
  23. Long-term Real-world Protection Afforded by Third mRNA Doses Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections, Coronavirus Disease 19-related Emergency Attendances and Hospitalizations Amongst Older Singaporeans During an Omicron XBB Wave · Liang En Wee · 2023 · 38 citations · Cited by this paper
  24. Divergent COVID-19 vaccine policies: Policy mapping of ten European countries · Robin van Kessel · 2023 · 34 citations · Cited by this paper
  25. A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants · Shangchen Song · 2024 · 32 citations · Cited by this paper
  26. Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents · Yoo-Yeon Kim · 2022 · 31 citations · Cited by this paper
  27. Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis · Obaidur Rahman · 2023 · 29 citations · Cited by this paper
  28. COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore · Wei Chong Tan · 2023 · 23 citations · Cited by this paper
  29. Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research · Berta Raventós · 2023 · 17 citations · Cited by this paper
  30. Monitoring COVID‐19 vaccine effectiveness against COVID‐19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022 · Irina Kislaya · 2023 · 14 citations · Cited by this paper
  31. Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study · Jennifer H Ku · 2023 · 12 citations · Cited by this paper
  32. Effectiveness and durability of a second COVID-19 booster against severe outcomes among older people in Norway: a population-based cohort study comparing mono- and bivalent booster doses · Melanie Stecher · 2023 · 12 citations · Cited by this paper
  33. COVID-19 vaccine booster doses provide increased protection against COVID-19 hospitalization compared with previously vaccinated individuals: Interim findings from the REFORCO-Brazil real-world effectiveness study during Delta and Omicron · Wilhelmine Hadler Meeraus · 2023 · 12 citations · Cited by this paper
  34. Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study · Wataru Mimura · 2023 · 11 citations · Cited by this paper
  35. A scoping review of COVID-19 vaccine hesitancy: refusal rate, associated factors, and strategies to reduce · Rona Bahreini · 2024 · 7 citations · Cited by this paper
  36. Comparing COVID-19 booster vaccine acceptance in the United Kingdom, Germany, Austria, and Jordan: The role of protection motivation theory, conspiracy beliefs, social media use and religiosity · Judith Eberhardt · 2024 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)